Brief: ISS Joins Glass Lewis In Recommending Aurinia Shareholders Vote “For” All Company Director Nominees
May 2 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* ISS JOINS GLASS LEWIS IN RECOMMENDING AURINIA SHAREHOLDERS
VOTE
“FOR” ALL COMPANY DIRECTOR NOMINEES AT 2023 ANNUAL GENERAL
MEETING
Source text for Eikon: ID:nBw9g7J0pa
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death